University of Nebraska Medical Center

Selected Publications

  1. Tarullo SE, He Y, Daughters C, Knutson TP, Henzler C, Price M, Shanley R, Witschen P, Tolg C, Kaspar RE, Hallstrom C, Gittsovich L, Sulciner ML, Zhang X, Forester C, Shats O, Desler MM, Cowan K, Yee D, Schwertfeger KL, Turley E, McCarthy JB, Nelson AC. Receptor for Hyaluronan-Mediated Motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. The Journal of Pathology. 2023. doi.org/10.1002/path.6082
  2. Dickinson K, Lim A, Kupzyk KA. Demographic, Symptom, and Lifestyle Factors Associated With Cancer-Related Fatigue in Men With Prostate Cancer. Oncol Nurs Forum. 2021 Jul 1;48(4):423-430. doi: 10.1188/21.ONF.423-430. PMID: 34142995.
  3. Zhang C, Plambeck BD, Craig ME, Tu A, Mikus RJ, Shostrom V, McDermott SP, Igbinigie I, Brown K, Cushman-Vokoun A, Foster JM. Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC. J Surg Oncol. 2021 Jun;123(7):1599-1609. doi: 10.1002/jso.26439. Epub 2021 Mar 5. PMID: 33667317.
  4. Foster JM, Patel A, Zhang C, Shostrom V, Brown K, Cushman-Vokoun AM. Investigating the utility of extended mutation analysis in gastrointestinal peritoneal metastasis. J Surg Oncol. 2020 Nov;122(6):1106-1113. doi: 10.1002/jso.26114. Epub 2020 Jul 13. PMID: 32662065.
  5. Griess B, Klinkebiel D, Kueh A, Desler M, Cowan K, Fitzgerald M, Teoh-Fitzgerald M. Association of SOD3 promoter DNA methylation with its down-regulation in breast carcinomas. Epigenetics. 2020 Jun 14:1-11. doi: 10.1080/15592294.2020.1777666. Epub ahead of print. PMID: 32508251.
  6. Cheng P-W, Davidson S, Bhat G. Markers of malignant prostate cancer cells: Golgi localization of α-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface. Biochem. Biophys Res. Commun. 2020 Jun 25;527(2):406-410. doi: 10.1016/j.bbrc.2020.03.168. Epub 2020 Apr 22
  7. LeVan TD, Xiao P, Kumar G, Kupzyk K, Qiu F, Klinkebiel D, Eudy J, Cowan K, Berger AM. Genetic Variants in Circadian Rhythm Genes and Self-Reported Sleep Quality in Women with Breast Cancer. J Circadian Rhythms.2019 Jul 1;17:6. doi:10.5334/jcr.184. PubMed PMID: 31303884; PubMed Central PMCID: PMC6611482.
  8. Maxwell J, Shats O, Aldridge J, Lyden E, Krie A, Conklin R, Manning K, Fahed R, Vaziri I, Deveras RAE, Mateen Z, Crow K, Bjorling V, Meschi JT, Makoni S, Kruter F, Cowan K. The impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis. Breast J. 2019 Jun 11. doi:10.1111/tbj.13373. [Epub ahead of print] PubMed PMID: 31187577.
  9. Berger AM, Kupzyk KA, Djalilova DM, Cowan KH. Breast Cancer Collaborative Registry informs understanding of factors predicting sleep quality. Support Care Cancer. 2019 Apr;27(4):1365-1373. doi: 10.1007/s00520-018-4417-5. PubMed PMID: 30112722; PubMed Central PMCID: PMC6423512.
  10. Manca S, Frisbie CP, LaGrange CA, Casey CA, Riethoven JM, Petrosyan A. The Role of Alcohol-Induced Golgi Fragmentation for Androgen Receptor Signaling in Prostate Cancer. Mol Cancer Res. 2019;17(1):225-237. doi:10.1158/1541-7786.MCR-18-0577
  11. Corley, B., Bartelt-Hunt, S., Rogan, E., Coulter, D., Sparks, J., Baccaglini, L., Howell, M., Liaquat, S., Commack, R., and Kolok, A. Using watershed boundaries to map adverse health outcomes: Examples from Nebraska, USA. Environ. Health Insights, 12:1-10, 2018.
  12. Kolok, A.S., Ali, J.M., Rogan, E.G., and Bartelt-Hunt, S.L. The fate of synthetic and endogenous hormones used in the US beef and dairy industries and the potential for human exposure, Current Environ. Hlth. Reports, 5:225-232, 2018.
  13. Shats O, Goldner W, Feng J, Sherman A, Smith RB, and Sherman S. Thyroid Cancer and Tumor Collaborative Registry (TCCR). Cancer Inform. 2016:15 73-79. DOI: 10.4137/CIN.S32470.
  14. K Buddhdev, A Patel, X Peng, C Guda, J Baker, W Goldner. Whole Exome Sequencing in T1a Papillary Thyroid Carcinoma. ATA National Meeting Sept 2016, Denver, Co. Published in Thyroid, Sept 2016;26(s1): P-1-A-129.doi:10.1089/thy.2016.29022.abstracts.
  15. Lynch H, Synder C, Wang SM. Considerations for comprehensive assessment of genetic predisposition in familial breast cancer. Breast J. 2015;21(1):67-75. PMID:25472498.
  16. Downs B, Kim YC, Xiao F, Snyder C, Chen P, Fleissner EA, Becirovic D, Wen H, Sherman S, Cowan KH, Lynch HT, Wang SM. Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer. Breast Cancer Research and Treatment, 151(1):219-224, 2015
  17. Stansifer KJ, Guynan JF, Wachal BM, and Smith RB. Modifiable risk factors and thyroid cancer. Otolaryngol Head Neck Surg. 2015 Mar;152(3):432-7. doi: 10.1177/0194599814564537.
  18. Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLoS One. 2015 Oct 2;10(10):e0139049. doi: 10.1371/journal.pone.0139049. eCollection 2015. PubMed PMID: 26431551; PubMed Central PMCID: PMC4592020.
  19. Visovsky C, Berger AM, Hertzog M, Rice J, Shade MY. Breast Cancer Collaborative Registry: Comparison of Physical and Mental Health and Sleep in Breast Cancer Survivors. Journal of Oncology Navigation & Survivorship. Oct2014, Vol. 5 Issue 5, p29.
  20. Wen H, Kim YC, Snyder C, Xiao F, Fleissner EA, Becirovic D, Luo J, Downs B, Sherman S, Cowan KH, Lynch HT, Wang SM. Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer. BMC Cancer. 2014 Jun 26;14:470. doi: 10.1186/1471-2407-14-470. PubMed PMID: 24969172.
  21. Xiao F, Kim YC, Snyder C, Wen H, Chen PX, Luo J, Becirovic D, Downs B, Cowan KH, Lynch H, Wang SM. Genome instability in blood cells of a BRCA1+ breast cancer family. BMC Cancer. 2014 May 19;14:342. doi: 10.1186/1471-2407-14-342. PubMed PMID: 24884718.
  22. Xiao F, Kim YC, Wen H, Luo J, Chen P, Cowan K, Wang SM. The genome of polymorphonuclear neutrophils maintains normal coding sequences. PLOSOne 8(11):e78685, 2013
  23. Lynch H, Wen H, Kim YC, Snyder C, Kinarsky Y, Chen PX, Xiao F, Goldgar D, Cowan KH, Wang SM. Can unknown predisposition in familial breast cancer be family-specific? Breast J. 2013 Sep-Oct;19(5):520-8. doi: 10.1111/tbj.12145. Epub 2013 Jun 26. PMID: 23800003
  24. Mdzinarishvili T, Sherman S. Basic Equations and Computing Procedures for Frailty Modeling of Carcinogenesis: Application to Pancreatic Cancer Data. Cancer Inform. 2013:12 67-81.
  25. Gleason M, Mdzinarishvili T, Are C, Sasson A, Sherman A, Shats O, and Sherman S. Prognostic Estimator of Survival for Patients with Localized and Extended Pancreatic Ductal Adenocarcinoma, Cancer Inform. 2013; 12: 103–114. doi:  10.4137/CIN.S11496. PMCID: PMC3616006
  26. Zahid M, Goldner W, Beseler C, Rogan E, Cavalieri E.  Unbalanced Estrogen Metabolism in Thyroid Cancer.  International Journal of Cancer. 2013 Dec 1;133(11):2642-9:   doi: 10.1002/ijc.28275
  27. Gleason M, Mdzinarishvili T and Sherman S. Breast Cancer Incidence in Black and White Women Stratified by Estrogen and Progesterone Receptor Statuses, PLoS ONE. 2012;7(11):e49359. doi: 10.1371.
  28. Baehr KM, Lyden E, Treude K, Erickson J, and Goldner W. Levothyroxine dose following thyroidectomy is affected by more than just body weight. Laryngoscope. 2012 Apr;122(4):834-8. doi: 10.1002/lary.23186.
  29. Anderson MA, Zolotarevsky E, Cooper KL, Sherman S, Shats O, Whitcomb DC, Lynch HT, Ghiorzo P, Rubinstein WS, Vogel KJ, Sasson AR, Grizzle WE, Ketcham MA, Lee SY, Normolle D, Plonka CM, Mertens AN, Tripon RC, Brand RE. Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study. Am J Gastroenterol. 2012 Aug 28. doi: 10.1038/ajg.2012.288. PubMed PMID: 22929760.
  30. Sherman S, Shats O, Fleissner E, Bascom G, Yiee K, Copur M, Crow K, Rooney J, Mateen Z, Ketcham MA, Feng J, Sherman A, Gleason M, Kinarsky L, Silva-Lopez E, Edney J, Reed E, Berger A, and Cowan K. Multicenter Breast Cancer Collaborative Registry, Cancer Inform. 2011; 10:217-226. PMCID:PMC3169352.
  31. Mdzinarishvili T, Gleason MX, Kinarsky L, and Sherman S. Extension of Cox Proportional Hazard Model for Estimation of Interrelated Age-Period-Cohort Effects on Cancer Survival, Cancer Inform. 2011; 10:31-44. PMCID: PMC3085422.
  32. Sherman S, Shats O, Ketcham MA, Anderson MA, Whitcomb DC, Lynch HT, Ghiorzo P, Rubinstein WS, Sasson AR, Grizzle WE, Haynatzi G, Feng J, Sherman A, Kinarsky, Brand RE.  PCCR: Pancreatic Cancer Collaborative Registry, Cancer Inform. 2011; 10:83-91. PMCID:PMC3085425.
  33. Mdzinarishvili T and Sherman S.  Weibull-like Model of Cancer Development in Aging.  Cancer Inform. 2010; 9:179-188. PMCID:PMC2935819.
  34. Mdzinarishvili T, Gleason MX, and Sherman S.  Estimation of Hazard Functions in the Log-Linear Age-Period-Cohort Model: Application to Lung Cancer Risk Associated with Geographical Area.  Cancer Inform. 2010; 9:67-78. PMCID:PMC2867636.
  35. Laney N, Meza J, Lyden E, Erickson J, Treude K, and Goldner W. The prevalence of Vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients.  Int J Endocrinol. 2010;2010:805716. doi: 10.1155/2010/805716.
  36. Mdzinarishvili T., Gleason MX, and Sherman S. A Novel Approach for Analysis of the Long-Linear Age-Period-Cohort Model: Application to Lung Cancer Incidence. Cancer Inform. 2009;7:271-280. PMCID:PMC2883306.
  37. Mdzinarishvili T, Gleason M, Kinarsky L, Sherman S. A Generalized Beta Model for the Age Distribution of Cancers: Application to Pancreatic and Kidney Cancer. Cancer Inform. 2009;7:183-197. PMCID: PMC2730181